Business Context and Reporting Period
This Form 8-K was filed by U.S. Auto Parts Network, Inc. (Carparts.Com, Inc.) on July 12, 2013. The report addresses a corporate governance issue regarding the composition of the Board of Directors and compliance with Nasdaq listing standards.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on regulatory compliance and does not contain financial performance data.
Material Changes
- Board Composition: The Company notified Nasdaq on July 9, 2013, that its Board of Directors no longer comprised a majority of independent directors, violating Nasdaq Listing Rule 5605(b)(1).
- Nasdaq Response: On July 12, 2013, the Company received a formal letter from Nasdaq acknowledging the notice and initiating the cure period process.
Guidance, Outlook, and Risks
- Management Action: The Company intends to regain compliance with the independent director requirement before the expiration of the cure period. A director search is currently underway to identify a new independent candidate.
- Risks: There is a risk that the Company may be unable to regain compliance with applicable Nasdaq Listing Rules, which could lead to delisting.
- Forward-Looking Statements: The Company disclaims any obligation to update forward-looking statements regarding the director search or compliance efforts.
Investor Verification Checklist
- Verify the current status of the independent director search and any appointments made since July 12, 2013.
- Confirm whether the Company successfully regained compliance with Nasdaq Listing Rule 5605(b)(1) within the cure period.
- Review the Company's Annual Report on Form 10-K for the fiscal year ended December 29, 2012, for detailed risk factors related to governance and delisting.